| Literature DB >> 27908365 |
E Charles Osterberg1, Gregory Murphy1, Catherine R Harris2, Benjamin N Breyer3.
Abstract
Following failed endoscopic intervention, the most cost-effective strategy for recurrent urethral stricture disease (USD) is urethroplasty. Inpatient hospital costs associated with urethroplasty are driven by patient comorbidities and postoperative complications. Symptom-based surveillance for USD recurrence will reduce unnecessary diagnostic procedures and cost. Copyright ÂEntities:
Keywords: Cost-effectiveness; Urethroplasty; Utilization
Mesh：
Year: 2017 PMID： 27908365 DOI： 10.1016/j.ucl.2016.08.002
Source DB: PubMed Journal: Urol Clin North Am ISSN： 0094-0143 Impact factor: 2.241